Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) EBITDA (2016 - 2025)

Historic EBITDA for INVO Fertility (IVF) over the last 17 years, with Q3 2025 value amounting to -$1.6 million.

  • INVO Fertility's EBITDA fell 2588.21% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.1 million, marking a year-over-year decrease of 31284.7%. This contributed to the annual value of -$8.0 million for FY2024, which is 1998.8% down from last year.
  • Latest data reveals that INVO Fertility reported EBITDA of -$1.6 million as of Q3 2025, which was down 2588.21% from -$3.0 million recorded in Q2 2025.
  • Over the past 5 years, INVO Fertility's EBITDA peaked at $514987.0 during Q4 2021, and registered a low of -$17.1 million during Q1 2025.
  • In the last 5 years, INVO Fertility's EBITDA had a median value of -$2.0 million in 2023 and averaged -$2.7 million.
  • As far as peak fluctuations go, INVO Fertility's EBITDA soared by 12884.56% in 2021, and later crashed by 104963.83% in 2025.
  • INVO Fertility's EBITDA (Quarter) stood at $514987.0 in 2021, then plummeted by 624.06% to -$2.7 million in 2022, then soared by 44.89% to -$1.5 million in 2023, then crashed by 131.05% to -$3.4 million in 2024, then surged by 53.32% to -$1.6 million in 2025.
  • Its EBITDA stands at -$1.6 million for Q3 2025, versus -$3.0 million for Q2 2025 and -$17.1 million for Q1 2025.